Loading...
XASXIDX
Market cap705mUSD
Dec 23, Last price  
2.91AUD
1D
-1.36%
1Q
5.05%
Jan 2017
144.54%
IPO
55.61%
Name

Integral Diagnostics Ltd

Chart & Performance

D1W1MN
XASX:IDX chart
P/E
—
P/S
2.41
EPS
—
Div Yield, %
1.22%
Shrs. gr., 5y
3.00%
Rev. gr., 5y
15.11%
Revenues
470m
+6.73%
3,230,0004,120,000151,213,000167,770,000179,732,000189,399,000232,393,000274,081,000348,808,000358,739,000440,099,000469,697,000
Net income
-61m
L
3,229,8393,423,6794,500,00011,388,00015,480,00015,079,00020,983,00023,033,00031,268,00014,603,00025,040,000-60,699,000
CFO
66m
-7.36%
3,739,8383,695,56017,112,00024,055,00022,730,00026,517,00033,923,00054,250,00069,572,00037,100,00071,418,00066,159,000
Dividend
Aug 30, 20240.033 AUD/sh
Earnings
Feb 18, 2025

Profile

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
URL
https://www.integraldiagnostics.com.au/
IPO date
Oct 21, 2015
Employees
2,010
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
469,697
6.73%
440,099
22.68%
358,739
2.85%
Cost of revenue
328,724
400,626
322,482
Unusual Expense (Income)
NOPBT
140,973
39,473
36,257
NOPBT Margin
30.01%
8.97%
10.11%
Operating Taxes
3,564
5,593
7,958
Tax Rate
2.53%
14.17%
21.95%
NOPAT
137,409
33,880
28,299
Net income
(60,699)
-342.41%
25,040
71.47%
14,603
-53.30%
Dividends
(13,822)
(12,640)
(20,863)
Dividend yield
2.22%
1.63%
3.25%
Proceeds from repurchase of equity
1,721
2,203
(24,324)
BB yield
-0.28%
-0.28%
3.79%
Debt
Debt current
16,170
16,668
17,210
Long-term debt
477,458
477,864
323,782
Deferred revenue
129,456
110,724
Other long-term liabilities
11,425
34,017
17,759
Net debt
451,185
460,662
217,640
Cash flow
Cash from operating activities
66,159
71,418
37,100
CAPEX
(23,878)
(43,995)
(27,770)
Cash from investing activities
(27,903)
(128,958)
(55,693)
Cash from financing activities
(29,454)
(31,849)
81,134
FCF
145,353
(13,313)
8,651
Balance
Cash
42,438
33,855
123,193
Long term investments
5
15
159
Excess cash
18,958
11,865
105,415
Stockholders' equity
301,707
373,048
347,244
Invested Capital
650,507
742,687
599,978
ROIC
19.73%
5.05%
5.01%
ROCE
20.94%
5.12%
5.04%
EV
Common stock shares outstanding
233,497
235,795
211,869
Price
2.67
-18.60%
3.28
8.25%
3.03
-41.73%
Market cap
623,436
-19.39%
773,409
20.48%
641,962
-38.70%
EV
1,074,621
1,234,071
859,602
EBITDA
140,973
82,959
72,956
EV/EBITDA
7.62
14.88
11.78
Interest
22,313
18,295
10,483
Interest/NOPBT
15.83%
46.35%
28.91%